The Institute of Medicine treats 20 ng/mL as adequate for bone health. The Endocrine Society’s 2011 guideline used 30; its 2024 update found no clear evidence for a single target. Executive Health Edge draws it at month 0, 6, and 12; a low value is corrected by a standing supplement protocol, at a dose set by the physician, and confirmed at the next panel rather than guessed at.
What the number is
Vitamin D status is measured as 25-hydroxyvitamin D in the blood. Executive Health Edge draws it at month 0, 6, and 12 as part of the nutrient block with B12, folate, iron, ferritin, and transferrin.
The Institute of Medicine treats 20 ng/mL as adequate for bone health. The Endocrine Society’s 2011 guideline used 30; its 2024 update found no clear evidence for a single target. Your physician decides which target applies to you.
Why it is so often low in this demographic
An executive spends his daylight indoors, applies sunscreen when he is not, lives somewhere the winter sun is too weak to matter, and may carry more body fat than he did at 30, which sequesters the vitamin. The result is a common finding on a month 0 panel.
What it affects
Bone health over the long run, which is where the evidence is clearest; research on other benefits is inconsistent. Men rarely feel low vitamin D as a specific symptom, and low levels are common enough to be worth checking, which is why it is a lab value and not a checklist item.
How it is corrected
By a standing protocol, not by guessing. A low result on the panel triggers a supplement dose set by the program physician, based on the starting value and body composition. The month 6 panel confirms the value landed in the target range and the dose is adjusted from there. That is the whole method. Megadoses without a lab result push men too high, and too high is its own problem.
What moves it apart from the supplement
- Sun exposure in the months and latitudes where it works.
- Body composition. As fat mass falls, the same dose produces a higher level.
- Dietary sources (fatty fish, fortified foods) help at the margin but rarely correct a deficiency on their own.
What the research says
- 20 ng/mL covers bone health for nearly everyone. The Institute of Medicine found that a 25-hydroxyvitamin D of at least 20 ng/mL meets the needs of at least 97.5% of the population, based on bone health (Ross et al., Journal of Clinical Endocrinology and Metabolism, 2011).
- The 30 ng/mL line came from the 2011 guideline. The Endocrine Society’s 2011 guideline defined 30 ng/mL as sufficient, 20 to 29 as insufficient, and under 20 as deficient (Holick et al., Journal of Clinical Endocrinology and Metabolism, 2011).
- The 2024 update dropped a single target. The Endocrine Society’s 2024 guideline found no clear evidence for a single optimal level, which is why the target is the physician’s call. The program still tests every client at month 0, 6, and 12, because a measured value beats a guessed dose (Demay et al., Journal of Clinical Endocrinology and Metabolism, 2024).
- Latitude decides winter sun. The skin made no vitamin D from November to February in Boston and from October to March in Edmonton, while production continued through winter farther south (Webb et al., Journal of Clinical Endocrinology and Metabolism, 1988).
- Body fat holds it back. Obese subjects had lower vitamin D levels and a 57% smaller rise after UV exposure, likely because vitamin D is deposited in body fat (Wortsman et al., American Journal of Clinical Nutrition, 2000).
What goes to the physician
The dose. Any value the lab flags, any value that does not respond to the protocol, and anything that suggests a cause beyond sun and body fat route to the program physician in writing.
This page is coaching information, not medical advice. Questions about medication, hormones, or peptides go to the program physician.